lifestyle.lincolnlabs.com

Author: Jade Biosciences

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 23, 2026
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer

April 22, 2026
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 6, 2026
Jade Biosciences to Participate in Upcoming Conferences

February 13, 2026